Abstract:Allergic rhinitis (AR) is frequently known as a chronic respiratory disease with global high prevalence. The pivotal roles of histone deacetylase 4 (HDAC4) in multiple human diseases have been underlined by numerous studies. Our paper is the first to explore the role of HDAC4 in AR and the mechanism involved. We concluded that HDAC4 inhibition activated SIRT1/NF‐κB signaling to mitigate inflammatory response and mucus production in interleukin‐13‐treated nasal epithelial cells in AR. Introduction Allergic rhinitis (AR) is frequently known as a chronic respiratory disease with a global high prevalence. The pivotal roles of histone deacetylase 4 (HDAC4) in multiple human diseases have been underlined by numerous studies. Nevertheless, whether HDAC4 is implicated in AR remains to be elaborated. The objective of the current study is to clarify the impacts of HDAC4 on AR. Methods First, human nasal epithelial cells (hNECs) were pretreated by interleukin‐13 (IL‐13). HDAC4 expression in hNECs with the presence or absence of IL‐13 treatment was tested by quantitative reverse‐transcription polymerase chain reaction (RT‐qPCR) and western blot. Following, after HDAC4 was depleted, levels of histamine, Immunoglobulin E (IgE) and inflammatory factors were analyzed by ELISA assay. Then, Mucin‐5AC (MUC5AC) expression was examined through RT‐qPCR, western blot, and IF assay. Western blot was to analyze the expression of sirtuin 1 (SIRT1)/nuclear factor‐kappaB (NF‐κB) signaling‐related proteins. After IL‐13‐induced hNECs were cotransfected with HDAC4 interference plasmids and SIRT1 inhibitor EX527, the functional experiments above were conducted again. Results The experimental data in this study presented that HDAC4 expression was increased in IL‐13‐induced hNECs. Silencing of HDAC4 cut down the levels of histamine, IgE and inflammatory factors and the expression of MUC5AC. Additionally, knockdown of HDAC4 led to the activation of SIRT1/NF‐κB signaling. Further, the downregulated levels of histamine, IgE and inflammatory factors and the expression of MUC5AC imposed by HDAC4 interference were all reversed by EX527. Conclusions In short, HDAC4 inhibition activated SIRT1/NF‐κB signaling to mitigate inflammatory response and mucus production in IL‐13‐treated nasal epithelial cells in AR.

An aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress the Th17 response in allergic rhinitis patients

Tcdd-Induced Activation Of Aryl Hydrocarbon Receptor Inhibits Th17 Polarization And Regulates Non-Eosinophilic Airway Inflammation In Asthma

Hypoxia Disrupts Aryl Hydrocarbon Receptor Signaling and the Th17 Response in Allergic Rhinitis Patients.

Anti-inflammatory Mechanisms of IL-38 in Chinese Patients with Allergic Rhinitis

Derp1-modified dendritic cells attenuate allergic inflammation by regulating the development of T helper type1(Th1)/Th2 cells and regulatory T cells in a murine model of allergic rhinitis

Inhibition of dendritic cell autophagy alleviates the progression of allergic rhinitis by inhibiting Th1/Th2/Th17 immune imbalance and inflammation

Chlorogenic acid ameliorated allergic rhinitis-related symptoms in mice by regulating Th17 cells

A possible role of CD4+CD25+ T cells as well as transcription factor Foxp3 in the dysregulation of allergic rhinitis.

ARYL HYDROCARBON RECEPTOR ACTIVATION AMELIORATES EXPERIMENTAL COLITIS BY MODULATING THE TOLEROGENIC DENDRITIC AND REGULATORY T CELL FORMATION

Inhibition of TRPA1 Reduces Airway Inflammation and Hyperresponsiveness in Mice with Allergic Rhinitis.

Tangeretin Promotes Regulatory T Cell Differentiation by Inhibiting Notch1/Jagged1 Signaling in Allergic Rhinitis.

Role of the Aryl Hydrocarbon Receptor in the Pathogenesis of Chronic Rhinosinusitis with Nasal Polyps

Role of Th2, Th17 and Treg Cells and relevant cytokines in pathogenesis of allergic rhinitis

Tolerogenic dendritic cells and TLR4/IRAK4/NF-κB signaling pathway in allergic rhinitis

Tolerogenic dendritic cells and TLR4/IRAK4/NF-B signaling pathway in allergic rhinitis

Peripheral Th17/Treg cell-mediated immunity imbalance in allergic rhinitis patients.

Prostaglandin E2 Signal Inhibits T Regulatory Cell Differentiation During Allergic Rhinitis Inflammation Through EP4 Receptor.

HDAC4 depletion ameliorates IL‐13‐triggered inflammatory response and mucus production in nasal epithelial cells via activation of SIRT1/NF‐κB signaling

Differential Modulation of Dendritic Cell Biology by Endogenous and Exogenous Aryl Hydrocarbon Receptor Ligands

An endogenous aryl hydrocarbon receptor ligand, ITE, induces regulatory T cells and ameliorates experimental colitis

Apigenin attenuates inflammatory response in allergic rhinitis mice by inhibiting the TLR4/MyD88/NF-κB signaling pathway